These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 27228995)

  • 1. Bidirectional signalling between EphA2 and ephrinA1 increases tubular cell attachment, laminin secretion and modulates erythropoietin expression after renal hypoxic injury.
    Rodriguez S; Rudloff S; Koenig KF; Karthik S; Hoogewijs D; Huynh-Do U
    Pflugers Arch; 2016 Aug; 468(8):1433-48. PubMed ID: 27228995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin-Producing Hepatoma Receptor Tyrosine Kinase A2 Modulation Associates with Protective Effect of Prone Position in Ventilator-induced Lung Injury.
    Park BH; Shin MH; Douglas IS; Chung KS; Song JH; Kim SY; Kim EY; Jung JY; Kang YA; Chang J; Kim YS; Park MS
    Am J Respir Cell Mol Biol; 2018 Apr; 58(4):519-529. PubMed ID: 29216437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of EphA2 during in vivo and in vitro renal ischemia-reperfusion injury: role of Src kinases.
    Baldwin C; Chen ZW; Bedirian A; Yokota N; Nasr SH; Rabb H; Lemay S
    Am J Physiol Renal Physiol; 2006 Nov; 291(5):F960-71. PubMed ID: 16735461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model.
    Tandon M; Vemula SV; Sharma A; Ahi YS; Mittal S; Bangari DS; Mittal SK
    J Gene Med; 2012 Feb; 14(2):77-89. PubMed ID: 22228563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma.
    Li X; Wang L; Gu JW; Li B; Liu WP; Wang YG; Zhang X; Zhen HN; Fei Z
    Tumour Biol; 2010 Oct; 31(5):477-88. PubMed ID: 20571968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatially modulated ephrinA1:EphA2 signaling increases local contractility and global focal adhesion dynamics to promote cell motility.
    Chen Z; Oh D; Biswas KH; Yu CH; Zaidel-Bar R; Groves JT
    Proc Natl Acad Sci U S A; 2018 Jun; 115(25):E5696-E5705. PubMed ID: 29866846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of EphA2/EphrinA1 signal attenuates lipopolysaccharide-induced lung injury.
    Hong JY; Shin MH; Douglas IS; Chung KS; Kim EY; Jung JY; Kang YA; Kim SK; Chang J; Kim YS; Park MS
    Clin Sci (Lond); 2016 Nov; 130(21):1993-2003. PubMed ID: 27549114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Expression of ephrinA1/ephA2 Receptor Increases in Chronic Rhinosinusitis and ephrinA1/ephA2 Signaling Affects Rhinovirus-Induced Innate Immunity in Human Sinonasal Epithelial Cells.
    Lee SH; Kang SH; Han MS; Kwak JW; Kim HG; Lee TH; Lee DB; Kim TH
    Front Immunol; 2021; 12():793517. PubMed ID: 34975898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expressions of angiogenesis-related factors: CD105, EphA2 and EphrinA1 in laryngeal squamous cell carcinoma and clinical implication].
    Su J; Ji XB; Xie JH; Li W
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Dec; 51(12):929-936. PubMed ID: 27978884
    [No Abstract]   [Full Text] [Related]  

  • 10. The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.
    Wykosky J; Debinski W
    Mol Cancer Res; 2008 Dec; 6(12):1795-806. PubMed ID: 19074825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor.
    Wykosky J; Palma E; Gibo DM; Ringler S; Turner CP; Debinski W
    Oncogene; 2008 Dec; 27(58):7260-73. PubMed ID: 18794797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice.
    Whitehurst KS; Chan VA; Estes HK; Valsaraj S; Kent S; Sharma UM; Chase RC; Bhuiyan M; Virag JAI
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-trans retinoic acid attenuates bleomycin-induced pulmonary fibrosis via downregulating EphA2-EphrinA1 signaling.
    Leem AY; Shin MH; Douglas IS; Song JH; Chung KS; Kim EY; Jung JY; Kang YA; Chang J; Kim YS; Park MS
    Biochem Biophys Res Commun; 2017 Sep; 491(3):721-726. PubMed ID: 28743499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial organization of EphA2 at the cell-cell interface modulates trans-endocytosis of ephrinA1.
    Greene AC; Lord SJ; Tian A; Rhodes C; Kai H; Groves JT
    Biophys J; 2014 May; 106(10):2196-205. PubMed ID: 24853748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of erythropoietin-producing hepatocellular receptor A2 attenuates cell adhesion of human fallopian tube epithelial cells via focal adhesion kinase dephosphorylation.
    Yang XY; Zhu WJ; Jiang H
    Mol Cell Biochem; 2012 Feb; 361(1-2):259-65. PubMed ID: 22009484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EphA2/ephrinA1 mRNA expression and protein production in adenoid cystic carcinoma of salivary gland.
    Shao Z; Zhu F; Song K; Zhang H; Liu K; Shang Z
    J Oral Maxillofac Surg; 2013 May; 71(5):869-78. PubMed ID: 23298804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EphA2 as a novel molecular marker and target in glioblastoma multiforme.
    Wykosky J; Gibo DM; Stanton C; Debinski W
    Mol Cancer Res; 2005 Oct; 3(10):541-51. PubMed ID: 16254188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of EphA2 and EphrinA1 in human renal cell carcinoma and its relationship with angiogenesis].
    Xu JS; Zhang JX; Geng TH; Wang YF; Wang XL; Zuo LF
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):438-41. PubMed ID: 19950554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia.
    Cercone MA; Schroeder W; Schomberg S; Carpenter TC
    Am J Physiol Lung Cell Mol Physiol; 2009 Nov; 297(5):L856-63. PubMed ID: 19684201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1.
    Noblitt LW; Bangari DS; Shukla S; Knapp DW; Mohammed S; Kinch MS; Mittal SK
    Cancer Gene Ther; 2004 Nov; 11(11):757-66. PubMed ID: 15359289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.